Literature DB >> 18307207

Spectrum and outcome of prenatally diagnosed fetal tumors.

D Kamil1, J Tepelmann, C Berg, A Heep, R Axt-Fliedner, U Gembruch, A Geipel.   

Abstract

OBJECTIVE: To describe the spectrum of prenatally diagnosed fetal tumors, and the course and fetal outcome in affected pregnancies.
METHODS: This was a retrospective study in two German tertiary referral centers of 84 fetuses with tumors diagnosed in the prenatal period. The tumors were classified according to their location and histology.
RESULTS: The most common site of origin was the heart (20/84, 23.8%), followed by the face and neck region (19/84, 22.6%) and the abdomen (16/84, 19%). Lymphangiomas (21/84, 25%) and rhabdomyomas (19/84, 22.6%) comprised half of the tumor histology. Less frequently, teratomas (14/84, 16.6%) and hemangiomas (12/84, 14.2%) were seen. Complications included arrhythmia in cases with rhabdomyoma (8/19, 42%) and signs of heart failure in cases with hemangioma (4/12, 33%) and teratoma (4/14, 28.6%). The overall survival rate was 75%. Cases with either a histological diagnosis of teratoma or tumor located in the brain had the worst prognosis.
CONCLUSION: The combination of sonographic features and their location allows reliable prediction of the histological type in the vast majority of fetal tumors. Malignancy, associated malformations and aneuploidy are observed infrequently. Knowledge of the presence of a fetal tumor facilitates close surveillance by a specialized team, which might lead to early recognition of problems and improve perinatal outcome. Copyright (c) 2008 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18307207     DOI: 10.1002/uog.5260

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  14 in total

1.  Medical and ethical challenges in the case of a prenatally undiagnosed massive congenital brain tumor.

Authors:  M Olischar; T Stavroudis; J K Karp; W E Kaufmann; C Theda
Journal:  J Perinatol       Date:  2015-09       Impact factor: 2.521

2.  Successful prenatal and perinatal management of a massive cervicofacial teratoma.

Authors:  Kyoko Ono; Shunsuke Tamaru; Akihiko Kikuchi; Kaori Ishikawa; Tsuguhiro Horikoshi; Kimiyo Takagi; Susumu Miyashita; Shigeru Takamizawa
Journal:  J Med Ultrason (2001)       Date:  2011-05-26       Impact factor: 1.314

Review 3.  Fetal head and neck tumors.

Authors:  Tamara Feygin; Larissa T Bilaniuk
Journal:  Pediatr Radiol       Date:  2020-11-30

4.  Fetal arrhythmias associated with cardiac rhabdomyomas.

Authors:  Annette Wacker-Gussmann; Janette F Strasburger; Bettin F Cuneo; Delonia L Wiggins; Nina L Gotteiner; Ronald T Wakai
Journal:  Heart Rhythm       Date:  2013-12-11       Impact factor: 6.343

Review 5.  Imaging of fetal brain tumors.

Authors:  Patricia Cornejo; Tamara Feygin; Jennifer Vaughn; Cory M Pfeifer; Alexandra Korostyshevska; Mittun Patel; Dianna M E Bardo; Jeffrey Miller; Luis F Goncalves
Journal:  Pediatr Radiol       Date:  2020-11-30

Review 6.  Tumours of the fetal body: a review.

Authors:  Fred E Avni; Anne Massez; Marie Cassart
Journal:  Pediatr Radiol       Date:  2009-02-24

7.  Fetal suprarenal masses--assessing the complementary role of magnetic resonance and ultrasound for diagnosis.

Authors:  Siobhan M Flanagan; Erika Rubesova; Diego Jaramillo; Richard A Barth
Journal:  Pediatr Radiol       Date:  2015-11-20

8.  Congenital tumors: imaging when life just begins.

Authors:  Leonor Alamo; Maja Beck-Popovic; François Gudinchet; Reto Meuli
Journal:  Insights Imaging       Date:  2011-02-14

Review 9.  Fetal tumors: prenatal ultrasonographic findings and clinical characteristics.

Authors:  Jeong Yeon Cho; Young Ho Lee
Journal:  Ultrasonography       Date:  2014-06-20

10.  Lymphangioma of the fetal neck within the PIK3CA-related-overgrowth spectrum (PROS): A case report.

Authors:  Jann Lennard Scharf; Michael Gembicki; Christoph Dracopoulos; Yorck Hellenbroich; Anne Offermann; Guido Stichtenoth; Kianusch Tafazzoli-Lari; Lars Tharun; Jan Weichert
Journal:  Clin Case Rep       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.